神経血管カテーテル市場：タイプ、用途、最終用途別-2025-2030年の世界予測

神経血管カテーテル市場は、2023年に43億7,000万米ドルと評価され、2024年には49億米ドルに達すると予測され、CAGR 12.01％で成長し、2030年には96億8,000万米ドルに達すると予測されています。

脳血管障害の治療に不可欠な神経血管カテーテルには、塞栓術、血栓除去術、血管形成術などの診断および介入的神経血管処置に使用される機器が含まれます。神経血管疾患の有病率の増加、低侵襲手術の技術的進歩、ヘルスケア支出の増大がこれらの機器の需要を牽引しており、患者の転帰を向上させるための開発が必要とされています。主な用途は病院や神経科専門クリニックであり、最終用途は神経血管疾患の影響を受けやすい老年人口の増加に大きく影響されます。現在の市場成長は、手技の有効性と安全性を向上させる柔軟性、耐久性、追跡可能な素材など、カテーテル技術の急速な進歩によって支えられています。カテーテル手技におけるロボット工学とAIの統合は、精度の向上とヒューマンエラーの低減という大きな成長機会をもたらします。企業は、スマートカテーテル技術の研究開発に投資し、新興市場での応用を拡大することで、こうした機会を生かすことができます。しかし、課題としては、厳しい規制当局の承認や技術革新に伴う高コストなどがあり、これが市場の成長を阻害する可能性があります。また、複雑な神経血管インターベンションを実施できる熟練した専門家の数が限られていることも、普及の妨げになる可能性があります。技術革新は、カテーテルの柔軟性、生体適合性の向上、さまざまな神経血管処置を支援できる多機能カテーテルの開発に的を絞ることができ、複数の医療介入の必要性を減らすことができます。市場関係者は、幅広いアクセスを確保するための流通網の強化にも注力すべきです。北米と欧州は現在、先進的なヘルスケア・インフラを背景に市場を独占しているが、アジア太平洋地域は医療予算の増加と神経血管の健康に対する意識の高まりにより、有利な可能性を秘めており、企業はポートフォリオを拡大することができます。全体として、市場が発展するにつれ、技術の進歩や患者中心のイノベーションに対応し続けることが、この活発な領域で持続的な事業成長を遂げるために極めて重要になります。

市場力学：急速に進化する神経血管カテーテル市場の主要市場インサイトを公開

神経血管カテーテル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 低侵襲脳手術への急速なシフト
  • 健康に関する政府の支援政策と意識向上
  • 神経疾患の有病率の上昇
• 市場抑制要因
  • カテーテル閉塞のリスク
• 市場機会
  • 神経血管カテーテルにおける技術開発
  • カテーテル設計の継続的進歩
• 市場の課題
  • 神経血管臓器に対する生体適合性の限界

ポーターの5つの力：神経血管カテーテル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経血管カテーテル市場における外部からの影響の把握

外部マクロ環境要因は、神経血管カテーテル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経血管カテーテル市場における競合情勢の把握

神経血管カテーテル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経血管カテーテル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経血管カテーテル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経血管カテーテル市場における成功への道筋を描く

神経血管カテーテル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 低侵襲脳手術への急速な移行
    • 健康に関する政府の支援政策と意識啓発
    • 神経疾患の罹患率の上昇
  • 抑制要因
    • カテーテル閉塞のリスク
  • 機会
    • 神経血管カテーテルにおける技術開発
    • カテーテル設計の継続的な進歩
  • 課題
    • 神経血管器官との生体適合性に関する制限
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経血管カテーテル市場：タイプ別

• アクセスカテーテル
• バルーンカテーテル
• 塞栓カテーテル
• マイクロカテーテル

第7章 神経血管カテーテル市場：用途別

• 動静脈奇形
• 脳動脈瘤
• 塞栓性脳卒中

第8章 神経血管カテーテル市場：最終用途別

• 外来手術センター
• クリニック
• 診断センター
• 病院

第9章 南北アメリカの神経血管カテーテル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の神経血管カテーテル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの神経血管カテーテル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acandis GmbH
• Access Vascular, Inc.
• Balt USA LLC
• Biomerics LLC
• ICU Medical, Inc.
• Imperative Care Inc.
• Integra Lifesciences Corporation
• Johnson & Johnson Services, Inc.
• Medtronic Plc
• Microvention Inc. by Terumo Corporation
• Penumbra, Inc.
• Shape Memory Medical Inc.
• Spiegelberg Gmbh & Co. KG
• Stryker Corporation
• TE Connectivity
• Teleflex Incorporated
• Zeus Industrial Products, Inc.

LIST OF FIGURES

• FIGURE 1. NEUROVASCULAR CATHETERS MARKET RESEARCH PROCESS
• FIGURE 2. NEUROVASCULAR CATHETERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROVASCULAR CATHETERS MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ACCESS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIC STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

The Neurovascular Catheters Market was valued at USD 4.37 billion in 2023, expected to reach USD 4.90 billion in 2024, and is projected to grow at a CAGR of 12.01%, to USD 9.68 billion by 2030.

Neurovascular catheters, integral to the treatment of cerebral vascular disorders, encompass devices used in diagnostic and interventional neurovascular procedures such as embolization, thrombectomy, and angioplasty. The increasing prevalence of neurovascular diseases, technological advancements in minimally invasive surgery, and growing healthcare expenditure drive the demand for these devices, necessitating their development to enhance patient outcomes. Primary applications lie in hospitals and specialized neurology clinics, while end-use dynamics are heavily influenced by the rise in geriatric populations susceptible to neurovascular conditions. Current market growth is buoyed by rapid advancements in catheter technology, including flexible, durable, and trackable materials that improve procedural efficacy and safety. The integration of robotics and AI in catheter procedures presents significant growth opportunities, enhancing precision and reducing human error. Companies can capitalize on these opportunities by investing in R&D for smart catheter technologies and expanding their application in emerging markets. However, challenges include stringent regulatory approvals and high costs associated with innovation, which can impede market growth. Another limitation is the limited number of skilled professionals to perform complex neurovascular interventions, which may hinder widespread adoption. Innovation can be targeted towards enhancing catheter flexibility, biocompatibility, and the development of multifunctional catheters that can assist in various neurovascular procedures, reducing the need for multiple medical interventions. Market players should also focus on strengthening distribution networks to ensure broad accessibility. With North America and Europe currently dominating the market due to advanced healthcare infrastructure, tapping into Asia-Pacific regions presents lucrative potential owing to an increasing healthcare budget and growing awareness of neurovascular health, allowing businesses to expand their portfolio. Overall, as the market evolves, staying attuned to technological advancements and patient-centered innovations will be crucial for sustained business growth in this thriving domain.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Catheters Market

The Neurovascular Catheters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid shift to minimally invasive brain surgeries
  • Supportive government policies concerning health and creating awareness
  • Rising prevalence of neurological conditions
• Market Restraints
  • Risk of catheter blockage
• Market Opportunities
  • Technological development in neurovascular catheters
  • Ongoing advances in designs of catheters
• Market Challenges
  • Limitation in terms of biocompatibility with neurovascular organs

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Catheters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Catheters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Catheters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Catheters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Catheters Market

A detailed market share analysis in the Neurovascular Catheters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Catheters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Catheters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Catheters Market

A strategic analysis of the Neurovascular Catheters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, Access Vascular, Inc., Balt USA LLC, Biomerics LLC, ICU Medical, Inc., Imperative Care Inc., Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Microvention Inc. by Terumo Corporation, Penumbra, Inc., Shape Memory Medical Inc., Spiegelberg Gmbh & Co. KG, Stryker Corporation, TE Connectivity, Teleflex Incorporated, and Zeus Industrial Products, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Access Catheters, Balloon Catheters, Embolization Catheters, and Microcatheters.
• Based on Application, market is studied across Arteriovenous Malformations, Brain Aneurysm, and Embolic Stroke.
• Based on End-use, market is studied across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid shift to minimally invasive brain surgeries
    • 5.1.1.2. Supportive government policies concerning health and creating awareness
    • 5.1.1.3. Rising prevalence of neurological conditions
  • 5.1.2. Restraints
    • 5.1.2.1. Risk of catheter blockage
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological development in neurovascular catheters
    • 5.1.3.2. Ongoing advances in designs of catheters
  • 5.1.4. Challenges
    • 5.1.4.1. Limitation in terms of biocompatibility with neurovascular organs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurovascular Catheters Market, by Type

• 6.1. Introduction
• 6.2. Access Catheters
• 6.3. Balloon Catheters
• 6.4. Embolization Catheters
• 6.5. Microcatheters

7. Neurovascular Catheters Market, by Application

• 7.1. Introduction
• 7.2. Arteriovenous Malformations
• 7.3. Brain Aneurysm
• 7.4. Embolic Stroke

8. Neurovascular Catheters Market, by End-use

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Clinics
• 8.4. Diagnostic Centers
• 8.5. Hospitals

9. Americas Neurovascular Catheters Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neurovascular Catheters Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Catheters Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acandis GmbH
• 2. Access Vascular, Inc.
• 3. Balt USA LLC
• 4. Biomerics LLC
• 5. ICU Medical, Inc.
• 6. Imperative Care Inc.
• 7. Integra Lifesciences Corporation
• 8. Johnson & Johnson Services, Inc.
• 9. Medtronic Plc
• 10. Microvention Inc. by Terumo Corporation
• 11. Penumbra, Inc.
• 12. Shape Memory Medical Inc.
• 13. Spiegelberg Gmbh & Co. KG
• 14. Stryker Corporation
• 15. TE Connectivity
• 16. Teleflex Incorporated
• 17. Zeus Industrial Products, Inc.